Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Inflammatory Bowel Diseases|June 23, 2018
Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBDJoseph A Picoraro, Dale Lee, Caren A Heller, et al.
Scientific Reports|August 18, 2016
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of childrenYetrib Hathout, Laurie S Conklin, Haeri Seol, et al.
Orphanet Journal of Rare Diseases|May 10, 2023
Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task ForceRima Nabbout, Galliano Zanello, Dixie Baker, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2014
Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertensionRobert S Stearman, Amber R Cornelius, Xiao Lu, et al.
Steroids|November 20, 2025
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year childrenSwati Mummidivarpu, Utkarsh J Dang, Michael Ziemba, et al.
Plos Medicine|September 21, 2020
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension studyEdward C Smith, Laurie S Conklin, Eric P Hoffman, et al.
Inflammatory Bowel Diseases|October 13, 2017
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBDDror S Shouval, Liza Konnikova, Alexandra E Griffith, et al.
Immunity|May 6, 2014
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage functionDror S Shouval, Amlan Biswas, Jeremy A Goettel, et al.
Neurology|August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle functionEric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Pharmacological Research|September 17, 2018
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drugLaurie S Conklin, Jesse M Damsker, Eric P Hoffman, et al.
Pageof 12